Significant differences in recurrence-free survival (RFS) and OS rates were observed in dedifferentiated liposarcoma patients as patients with PD-L1 positive tumours had worse RFS and OS compared to those with no PD-L1 expression. The gene discussed is CD274; the disease is neoplasm.